newsfilter
← Latest News
PR Newswire·

Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports

Public-private partnership to enable the development of innovative, sustainable infrastructure designed to set the global standard for travel biosecurity BOSTON and NEW YORK, Aug. 15, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE:DNA) and XpresSpa Group,